Nostrum Laboratories (Four Approved Abbreviated New Drug Applications ) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Asset Purch.
- Financing Rounds
-
1
Nostrum Laboratories (Four Approved Abbreviated New Drug Applications ) General Information
Description
Four approved abbreviated new drug applications based in Kansas City, Missouri.
Contact Information
Corporate Office
- Kansas City, MO
- United States
Corporate Office
- Kansas City, MO
- United States
Nostrum Laboratories (Four Approved Abbreviated New Drug Applications ) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Nostrum Laboratories (Four Approved Abbreviated New Drug Applications ) Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Nostrum Laboratories (Four Approved Abbreviated New Drug Applications ) FAQs
-
Where is Nostrum Laboratories (Four Approved Abbreviated New Drug Applications ) headquartered?
Nostrum Laboratories (Four Approved Abbreviated New Drug Applications ) is headquartered in Kansas City, MO.
-
What industry is Nostrum Laboratories (Four Approved Abbreviated New Drug Applications ) in?
Nostrum Laboratories (Four Approved Abbreviated New Drug Applications )’s primary industry is Buildings and Property.
-
Is Nostrum Laboratories (Four Approved Abbreviated New Drug Applications ) a private or public company?
Nostrum Laboratories (Four Approved Abbreviated New Drug Applications ) is a Private company.
-
What is the current valuation of Nostrum Laboratories (Four Approved Abbreviated New Drug Applications )?
The current valuation of Nostrum Laboratories (Four Approved Abbreviated New Drug Applications ) is .
-
What is Nostrum Laboratories (Four Approved Abbreviated New Drug Applications )’s current revenue?
The current revenue for Nostrum Laboratories (Four Approved Abbreviated New Drug Applications ) is .
-
Who are Nostrum Laboratories (Four Approved Abbreviated New Drug Applications )’s investors?
Nostrum Laboratories has invested in Nostrum Laboratories (Four Approved Abbreviated New Drug Applications ).
-
When was Nostrum Laboratories (Four Approved Abbreviated New Drug Applications ) acquired?
Nostrum Laboratories (Four Approved Abbreviated New Drug Applications ) was acquired on 29-Apr-2025.
-
Who acquired Nostrum Laboratories (Four Approved Abbreviated New Drug Applications )?
Nostrum Laboratories (Four Approved Abbreviated New Drug Applications ) was acquired by Strides Pharma Science.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process